Fiduciary Management Associates’s Charles River Laboratories CRL Stock Holding History

Fiduciary Management Associates’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-321,408	Closed	-$20.5M	–	119
2014 Q4	$20.5M	Sell	321,408 -44,922	-12%	-$2.82M	1.27%	42
2014 Q3	$21.9M	Sell	366,330 -7,570	-2%	-$433K	1.56%	7
2014 Q2	$20M	Buy	373,900 +24,100	+7%	+$1.32M	1.33%	31
2014 Q1	$21.1M	Buy	349,800 +200	+0.1%	+$11.7K	1.4%	19
2013 Q4	$18.5M	Sell	349,600 -5,930	-2%	-$298K	1.26%	38
2013 Q3	$16.4M	Buy	355,530 +43,150	+14%	+$1.98M	1.19%	44
2013 Q2	$12.8M	Buy	+312,380	New	+$13.4M	1%	70

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fiduciary Management Associates's CRL Position: Q1 2015 in Review

Fiduciary Management Associates sold out of Charles River Laboratories (CRL) in Q1 2015, closing a stake of 321,408 shares — an estimated $20.5M sold.

Fiduciary Management Associates first reported a position in CRL in Q2 2013 and held it in 7 quarters. The position peaked at $21.9M in Q3 2014. 259 funds tracked by Wall St. Rank hold CRL as of Q1 2015.

Fiduciary Management Associates reported no remaining Charles River Laboratories position as of Q1 2015 after selling out during the quarter.
Fiduciary Management Associates sold 321,408 Charles River Laboratories shares in Q1 2015, an estimated $20.5M.
Fiduciary Management Associates first reported a position in Charles River Laboratories in Q2 2013 and held it in 7 quarters.
Fiduciary Management Associates's Charles River Laboratories position peaked at $21.9M in Q3 2014.
259 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2015.

Based on Fiduciary Management Associates's 13F filing for Q1 2015, filed 14 May 2015.